This bill authorizes the Pennsylvania Department of General Services to transfer a 2.7-acre tract of land in Philadelphia, formerly part of the Eastern Pennsylvania Psychiatric Institute, to an organization called Gaudenzia DRC, Inc. for a nominal fee of one dollar. The transfer is conditional on the new owner using the property exclusively for drug and alcohol rehabilitation purposes, with a clause requiring the land to revert to the state if this restriction is violated or if the property is sold within 20 years. Additionally, the deal includes a permanent ban on using any part of the land for licensed gaming facilities, and the transaction requires final approval from the Governor.
This bill amends Pennsylvania's Insurance Company Law to update definitions and provisions related to health insurance coverage. It clarifies how certain government health programs are defined for insurance policies, specifically regarding prescription drug coverage and continuation of coverage for employees who lose their jobs. The legislation also updates the legal definition of a hospital to include facilities operating alcoholism or drug addiction treatment programs and establishes a Long-Term Care Partnership Program to help individuals manage future long-term care costs.
HB 2427 amends Pennsylvania's Insurance Company Law to regulate how insurers cover drugs for stage four, advanced metastatic cancer. The bill prohibits insurance policies from requiring patients to fail a different medication or prove a history of failure before approving coverage for a new drug, provided the drug is FDA-approved and aligns with current clinical best practices. This legislation also repeals the previous Fair Access to Cancer Treatment Law while ensuring that all existing rules, contracts, and decisions made under that law remain in effect.
HB 836 prohibits Pennsylvania from interfering with the use of medically appropriate assisted reproductive technology (ART), such as in vitro fertilization (IVF), ensuring individuals can access these services without state restrictions. The bill defines ART to include specific fertility procedures and requires that any new state laws must comply with this protection unless explicitly exempted by the legislature. It takes effect immediately, providing direct safeguards for individuals seeking ART services and healthcare providers offering them.
This bill creates a new chapter in Pennsylvania law to regulate medical devices by banning specific toxic chemicals known as ortho-phthalates, with a primary focus on DEHP. The legislation targets manufacturers of intravenous solution containers and tubing, which currently use these chemicals to make plastic flexible. By prohibiting the intentional addition of these substances, the bill aims to prevent the chemicals from leaching into patient fluids and reducing the effectiveness of cancer treatments. The law is based on findings that these compounds can act as endocrine disruptors, potentially harming reproductive health and contributing to drug resistance in cancer cells.
This Pennsylvania House Resolution designates the week of September 28 through October 4, 2026, as "Frontotemporal Degeneration Awareness Week" to highlight a rare and incurable brain disease. The measure directly affects residents of Pennsylvania who may be living with or caring for individuals diagnosed with frontotemporal degeneration, a condition that impacts behavior, speech, and movement. By officially recognizing this specific time period, the resolution aims to increase public understanding of the disease's symptoms and the need for better diagnosis and support. This is a commemorative action intended to draw attention to the condition rather than to enact new laws or funding.
This bill requires Pennsylvania's Department of Corrections to recognize medical diagnoses made by healthcare providers before an individual is incarcerated. It prohibits the department from removing or ignoring such diagnoses, except when a healthcare provider (who made the diagnosis or has relevant expertise) submits a written recommendation for removal. The department may then choose to remove the diagnosis based on that recommendation. This change directly affects individuals entering state prisons by ensuring their pre-incarceration medical conditions are acknowledged in their records. The law takes effect 60 days after enactment.
This Pennsylvania bill designates June 2026 as Aphasia Awareness Month to promote public understanding of aphasia, a language disorder often caused by strokes or brain injuries. The resolution aims to highlight the condition's impact on individuals and their communities while encouraging better diagnosis and treatment. It does not create new laws or funding but serves as a symbolic gesture to raise awareness within the state.
This Pennsylvania House resolution designates May 14, 2026, as "Apraxia Awareness Day" to highlight childhood apraxia of speech, a motor speech disorder affecting approximately 1 in 1,000 children. The bill aims to increase public understanding of the condition, which requires intensive speech therapy and can impact a child's ability to read, write, and communicate effectively. By encouraging residents to foster community awareness, the resolution seeks to support families and professionals working to help children with this neurological disorder develop their speech skills.
This Pennsylvania legislative resolution designates April 2026 as Esophageal Cancer Awareness and Prevention Month to highlight the disease's severity and promote public health awareness. The bill directly affects Pennsylvania residents by encouraging them to seek treatment for gastroesophageal reflux disease (GERD) to reduce their risk of developing esophageal cancer. It does not create new laws or funding but serves as a formal declaration to raise awareness about early detection and prevention strategies.
